crocin and Arthritis--Rheumatoid

crocin has been researched along with Arthritis--Rheumatoid* in 3 studies

Reviews

1 review(s) available for crocin and Arthritis--Rheumatoid

ArticleYear
Therapeutic effects of Crocin in autoimmune diseases: A review.
    BioFactors (Oxford, England), 2019, Volume: 45, Issue:6

    The immune system when acts against selfmolecules results in an imbalance in immunologic tolerance leading to the development of several autoimmune diseases (ADs) such as rheumatoid arthritis, asthma, ulcerative colitis, type 1 diabetes, and multiple sclerosis. Improved recognition of the mechanisms of ADs has led to the advancement of the management of these diseases. The principal mediators of ADs are inflammatory molecules. The herbal medicines due to their antioxidant and antiinflammatory properties have an important role in the management of ADs. Crocin is the principal chemical component extracted from saffron, which is a medicinal plant. This review focuses on the therapeutic effects of Crocin in various ADs.

    Topics: Anti-Inflammatory Agents; Antioxidants; Arthritis, Rheumatoid; Autoimmune Diseases; Carotenoids; Colitis, Ulcerative; Crocus; Diabetes Mellitus, Type 1; Humans; Multiple Sclerosis; Plant Extracts

2019

Other Studies

2 other study(ies) available for crocin and Arthritis--Rheumatoid

ArticleYear
Effects of crocin on inflammatory activities in human fibroblast-like synoviocytes and collagen-induced arthritis in mice.
    Immunologic research, 2018, Volume: 66, Issue:3

    Rheumatoid arthritis (RA) is a systemic autoimmune disease, characterized by the irreversible joint destruction resulted from the attack of inflammatory cells to the joints. Recent studies demonstrated that crocin is able to alleviate arthritis and suppress inflammatory responses, implying crocin as a potential promising antiarthritic agent. In this study, we confirmed the effect of crocin on RA and revealed its underlying mechanism by measuring lipopolysaccharides (LPS)-stimulated cytokine production in presence or absence of crocin. The effect of crocin was also tested in vivo using a mouse model of collagen-induced arthritis (CIA). It was found that crocin significantly repressed the LPS-induced expression of tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 in human fibroblast-like synoviocytes (FLS). We tested the effect of crocin on nuclear factor-kappa B (NF-κB) signaling and observed that cells pre-treated with 500 μM of crocin exhibited lower levels of LPS-induced p-IκBα, p-IκB kinase (IKK) α/β, and p65 expression than those of untreated cells. In addition, we found when cells were stimulated with IKKβ, crocin pre-treatment showed significantly inhibitory effect on the luciferase activity of IL-1β. In vivo results also showed that crocin treatment dramatically reduced plasma levels of TNF-α, IL-1β, and IL-6 in CIA mice. Crocin is efficient to suppress the productions of TNF-α, IL-6, and IL-1β by blocking NF-κB signal activation through its interaction with IKK, suggesting that crocin could be an efficient treatment for RA.

    Topics: Animals; Apoptosis; Arthritis, Experimental; Arthritis, Rheumatoid; Carotenoids; Cell Survival; Cells, Cultured; Crocus; Cytokines; Dose-Response Relationship, Drug; Fibroblasts; Humans; Inflammation Mediators; Mice; Synoviocytes

2018
Crocin reduces the inflammation response in rheumatoid arthritis.
    Bioscience, biotechnology, and biochemistry, 2017, Volume: 81, Issue:5

    This study is to determine the role and mechanism of crocin in rheumatoid arthritis (RA). Totally 60 Wistar SD rats were randomly divided into control group, RA model group, methotrexate group, crocin high dose, middle dose, and low dose groups. The paw swelling degree, arthritis score, thymus and spleen index, the mRNA and protein levels of iNOS, and the serum content of TNF-α, IL-1β, and IL-6 were evaluated. Crocin treatment significantly alleviated the paw swelling of RA rats. The arthritis score in crocin treatment groups was significantly lower than that in RA model group. Additionally, the thymus index, but not the spleen index, declined remarkably in crocin treatment groups than in RA model group. Besides, crocin administration significantly reduced the iNOS production and the serum content of TNF-α, IL-1β, and IL-6. Crocin may exert potent anti-RA effects through inhibiting cytokine.

    Topics: Animals; Arthritis, Rheumatoid; Carotenoids; Cytokines; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Inflammation; Male; Nitric Oxide Synthase Type II; Rats; Rats, Wistar; RNA, Messenger; Spleen; Thymus Gland

2017